Global Regenerative Medicines Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2014–2025
Regenerative medicines have the potential to heal damaged tissues and organs, completely. In this process, specific types of cells or cell products are delivered to diseased tissues or organs, where they ultimately restore tissue and organ function. This can be done through cell-based therapy or by using cell products, such as growth factors. Global regenerative medicines market is expected to grow at a CAGR of 24.2% from 2017 to 2025.
Based on type, the global regenerative medicines market is segmented as tissue engineering, cell therapy, small molecules & biologics, and gene therapy. By material, the market is divided into synthetic materials, genetically engineered materials, pharmaceuticals, and biologically derived materials. By application, the market is classified as cardiovascular, ophthalmology, dermatology, musculoskeletal, wound healing, oncology, neurology, and others. Geographically, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
MARKET DYNAMICS:
Drivers:
The top players in the global regenerative medicines market include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.
KEY TAKEAWAYS
MARKET LANDSCAPE
Based on type, the global regenerative medicines market is segmented as tissue engineering, cell therapy, small molecules & biologics, and gene therapy. By material, the market is divided into synthetic materials, genetically engineered materials, pharmaceuticals, and biologically derived materials. By application, the market is classified as cardiovascular, ophthalmology, dermatology, musculoskeletal, wound healing, oncology, neurology, and others. Geographically, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
MARKET DYNAMICS:
Drivers:
- Advancements in technology for tissue and organ regeneration.
- Increase in prevalence of chronic diseases.
- Rise in government and private funding for the development of regenerative medicines.
- Growth in geriatric population.
- High cost of regenerative medicines.
- Stringent governmental regulations.
The top players in the global regenerative medicines market include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.
KEY TAKEAWAYS
MARKET LANDSCAPE
- By Type
- Tissue Engineering
- Cell Therapy
- Small Molecules & Biologics
- Gene Therapy
- By Material
- Synthetic Materials
- Biodegradable Synthetic Polymers
- Hydrogel Material
- Scaffold
- Artificial Vascular Graft Materials
- Genetically Engineered Materials
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cells
- Three-Dimensional Polymer Technology
- Transgenic
- Fibroblasts
- Neural Stem Cells
- Gene-Activated Matrices
- Pharmaceuticals
- Small Molecules
- Biologics
- Biologically Derived Materials
- Collagen
- Xenogeneic Material
- By Application
- Cardiovascular
- Ophthalmology
- Dermatology
- Musculoskeletal
- Wound Healing
- Oncology
- Neurology
- Others
- By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
1. EXECUTIVE SUMMARY
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis
2. INTRODUCTION
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology
3. MARKET LANDSCAPE
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porter’s analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global regenerative medicines market shares analysis, 2014-2025
3.4.1. Global regenerative medicines market share by type, 2014-2025
3.4.2. Global regenerative medicines market share by material type, 2014-2025
3.4.3. Global regenerative medicines market share by application type, 2014-2025
3.4.4. Global regenerative medicines market share by geography, 2014-2025
4. GLOBAL REGENERATIVE MEDICINES MARKET BY TYPE
4.1. Tissue engineering
4.1.1. Historical market size by region, 2014-2016
4.1.2. Market forecast by region, 2017-2025
4.2. Cell therapy
4.2.1. Historical market size by region, 2014-2016
4.2.2. Market forecast by region, 2017-2025
4.3. Small molecules & biologics
4.3.1. Historical market size by region, 2014-2016
4.3.2. Market forecast by region, 2017-2025
4.4. Gene therapy
4.4.1. Historical market size by region, 2014-2016
4.4.2. Market forecast by region, 2017-2025
5. GLOBAL REGENERATIVE MEDICINES MARKET BY MATERIAL
5.1. Synthetic materials
5.1.1. Historical market size by region, 2014-2016
5.1.2. Market forecast by region, 2017-2025
5.1.3. Biodegradable synthetic polymers
5.1.3.1. Historical market size by region, 2014-2016
5.1.3.2. Market forecast by region, 2017-2025
5.1.4. Hydrogel material
5.1.4.1. Historical market size by region, 2014-2016
5.1.4.2. Market forecast by region, 2017-2025
5.1.5. Scaffold
5.1.5.1. Historical market size by region, 2014-2016
5.1.5.2. Market forecast by region, 2017-2025
5.1.6. Artificial vascular graft materials
5.1.6.1. Historical market size by region, 2014-2016
5.1.6.2. Market forecast by region, 2017-2025
5.2. Genetically engineered materials
5.2.1 Historical market size by region, 2014-2016
5.2.2 Market forecast by region, 2017-2025
5.2.3 Deoxyribonucleic acid transfection vectors
5.2.3.1. Historical market size by region, 2014-2016
5.2.3.2. Market forecast by region, 2017-2025
5.2.4 Genetically manipulated cells
5.2.4.1 Historical market size by region, 2014-2016
5.2.4.2 Market forecast by region, 2017-2025
5.2.5. Three-dimensional polymer technology
5.2.5.1. Historical market size by region, 2014-2016
5.2.5.2. Market forecast by region, 2017-2025
5.2.6. Transgenic
5.2.6.1. Historical market size by region, 2014-2016
5.2.6.2. Market forecast by region, 2017-2025
5.2.7. Fibroblasts
5.2.7.1. Historical market size by region, 2014-2016
5.2.7.2. Market forecast by region, 2017-2025
5.2.8. Neural stem cells
5.2.8.1. Historical market size by region, 2014-2016
5.2.8.2. Market forecast by region, 2017-2025
5.2.9. Gene-activated matrices
5.2.9.1. Historical market size by region, 2014-2016
5.2.9.2. Market forecast by region, 2017-2025
5.3. Pharmaceuticals
5.3.1. Historical market size by region, 2014-2016
5.3.2. Market forecast by region, 2017-2025
5.3.3. Small molecules
5.3.3.1. Historical market size by region, 2014-2016
5.3.3.2. Market forecast by region, 2017-2025
5.3.4. Biologics
5.3.4.1. Historical market size by region, 2014-2016
5.3.4.2. Market forecast by region, 2017-2025
5.4. Biologically derived materials
5.4.1. Historical market size by region, 2014-2016
5.4.2. Market forecast by region, 2017-2025
5.4.3. Collagen
5.4.3.1. Historical market size by region, 2014-2016
5.4.3.2. Market forecast by region, 2017-2025
5.4.4. Xenogeneic material
5.4.4.1. Historical market size by region, 2014-2016
5.4.4.2. Market forecast by region, 2017-2025
6. GLOBAL REGENERATIVE MEDICINES MARKET BY APPLICATION
6.1. Cardiovascular
6.1.1. Historical market size by region, 2014-2016
6.1.2. Market forecast by region, 2017-2025
6.2. Ophthalmology
6.2.1. Historical market size by region, 2014-2016
6.2.2. Market forecast by region, 2017-2025
6.3. Dermatology
6.3.1. Historical market size by region, 2014-2016
6.3.2. Market forecast by region, 2017-2025
6.4. Musculoskeletal
6.4.1. Historical market size by region, 2014-2016
6.4.2. Market forecast by region, 2017-2025
6.5. Wound healing
6.5.1. Historical market size by region, 2014-2016
6.5.2. Market forecast by region, 2017-2025
6.6. Oncology
6.6.1. Historical market size by region, 2014-2016
6.6.2. Market forecast by region, 2017-2025
6.7. Neurology
6.7.1. Historical market size by region, 2014-2016
6.7.2. Market forecast by region, 2017-2025
6.8. Others
6.8.1. Historical market size by region, 2014-2016
6.8.2. Market forecast by region, 2017-2025
7. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY
7.1. North America
7.1.1. U.S.
7.1.1.1. Historical market size, 2014-2016
7.1.1.2. Market forecast, 2017-2025
7.1.2. Canada
7.1.2.1. Historical market size, 2014-2016
7.1.2.2. Market forecast, 2017-2025
7.1.3. Mexico
7.1.3.1. Historical market size, 2014-2016
7.1.3.2. Market forecast, 2017-2025
7.2. Europe
7.2.1. UK
7.2.1.1. Historical market size, 2014-2016
7.2.1.2. Market forecast, 2017-2025
7.2.2. Germany
7.2.2.1. Historical market size, 2014-2016
7.2.2.2. Market forecast, 2017-2025
7.2.3. France
7.2.3.1. Historical market size, 2014-2016
7.2.3.2. Market forecast, 2017-2025
7.2.4. Spain
7.2.4.1. Historical market size, 2014-2016
7.2.4.2. Market forecast, 2017-2025
7.2.5. Italy
7.2.5.1. Historical market size, 2014-2016
7.2.5.2. Market forecast, 2017-2025
7.2.6. Rest of Europe
7.2.6.1. Historical market size, 2014-2016
7.2.6.2. Market forecast, 2017-2025
7.3. Asia-Pacific
7.3.1. China
7.3.1.1. Historical market size, 2014-2016
7.3.1.2. Market forecast, 2017-2025
7.3.2. Japan
7.3.2.1. Historical market size, 2014-2016
7.3.2.2. Market forecast, 2017-2025
7.3.3. India
7.3.3.1. Historical market size, 2014-2016
7.3.3.2. Market forecast, 2017-2025
7.3.4. Australia
7.3.4.1. Historical market size, 2014-2016
7.3.4.2. Market forecast, 2017-2025
7.3.5. South Korea
7.3.5.1. Historical market size, 2014-2016
7.3.5.2. Market forecast, 2017-2025
7.3.6. Rest of Asia-Pacific
7.3.6.1. Historical market size, 2014-2016
7.3.6.2. Market forecast, 2017-2025
7.4. LAMEA
7.4.1. Brazil
7.4.1.1. Historical market size, 2014-2016
7.4.1.2. Market forecast, 2017-2025
7.4.2. Saudi Arabia
7.4.2.1. Historical market size, 2014-2016
7.4.2.2. Market forecast, 2017-2025
7.4.3. South Africa
7.4.3.1. Historical market size, 2014-2016
7.4.3.2. Market forecast, 2017-2025
7.4.4. Rest of LAMEA
7.4.4.1. Historical market size, 2014-2016
7.4.4.2. Market forecast, 2017-2025
8. COMPANY PROFILES
8.1. Zimmer biomet holdings, inc.
8.1.1. Overview
8.1.2. Financials and business segments
8.1.3. Recent developments
8.2. Medtronic plc
8.2.1. Overview
8.2.2. Financials and business segments
8.2.3. Recent developments
8.3. Stryker corporation
8.3.1. Overview
8.3.2. Financials and business segments
8.3.3. Recent developments
8.4. Ocata therapeutics, inc.
8.4.1. Overview
8.4.2. Financials and business segments
8.4.3. Recent developments
8.5. Baxter international, inc.
8.5.1. overview
8.5.2. Financials and business segments
8.5.3. Recent developments
8.6. Depuy synthes
8.6.1. Overview
8.6.2. Financials and business segments
8.6.3. Recent developments
8.7. Organogenesis, inc.
8.7.1. Overview
8.7.2. Financials and business segments
8.7.3. Recent developments
8.8. Integra lifesciences holdings corporation
8.8.1. Overview
8.8.2. Financials and business segments
8.8.3. Recent developments
8.9. Acelity holdings, inc.
8.9.1. overview
8.9.2. Financials and business segments
8.9.3. Recent developments
8.10. Cryolife, inc.
8.10.1. Overview
8.10.2. Financials and business segments
8.10.3. Recent developments
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis
2. INTRODUCTION
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology
3. MARKET LANDSCAPE
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porter’s analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global regenerative medicines market shares analysis, 2014-2025
3.4.1. Global regenerative medicines market share by type, 2014-2025
3.4.2. Global regenerative medicines market share by material type, 2014-2025
3.4.3. Global regenerative medicines market share by application type, 2014-2025
3.4.4. Global regenerative medicines market share by geography, 2014-2025
4. GLOBAL REGENERATIVE MEDICINES MARKET BY TYPE
4.1. Tissue engineering
4.1.1. Historical market size by region, 2014-2016
4.1.2. Market forecast by region, 2017-2025
4.2. Cell therapy
4.2.1. Historical market size by region, 2014-2016
4.2.2. Market forecast by region, 2017-2025
4.3. Small molecules & biologics
4.3.1. Historical market size by region, 2014-2016
4.3.2. Market forecast by region, 2017-2025
4.4. Gene therapy
4.4.1. Historical market size by region, 2014-2016
4.4.2. Market forecast by region, 2017-2025
5. GLOBAL REGENERATIVE MEDICINES MARKET BY MATERIAL
5.1. Synthetic materials
5.1.1. Historical market size by region, 2014-2016
5.1.2. Market forecast by region, 2017-2025
5.1.3. Biodegradable synthetic polymers
5.1.3.1. Historical market size by region, 2014-2016
5.1.3.2. Market forecast by region, 2017-2025
5.1.4. Hydrogel material
5.1.4.1. Historical market size by region, 2014-2016
5.1.4.2. Market forecast by region, 2017-2025
5.1.5. Scaffold
5.1.5.1. Historical market size by region, 2014-2016
5.1.5.2. Market forecast by region, 2017-2025
5.1.6. Artificial vascular graft materials
5.1.6.1. Historical market size by region, 2014-2016
5.1.6.2. Market forecast by region, 2017-2025
5.2. Genetically engineered materials
5.2.1 Historical market size by region, 2014-2016
5.2.2 Market forecast by region, 2017-2025
5.2.3 Deoxyribonucleic acid transfection vectors
5.2.3.1. Historical market size by region, 2014-2016
5.2.3.2. Market forecast by region, 2017-2025
5.2.4 Genetically manipulated cells
5.2.4.1 Historical market size by region, 2014-2016
5.2.4.2 Market forecast by region, 2017-2025
5.2.5. Three-dimensional polymer technology
5.2.5.1. Historical market size by region, 2014-2016
5.2.5.2. Market forecast by region, 2017-2025
5.2.6. Transgenic
5.2.6.1. Historical market size by region, 2014-2016
5.2.6.2. Market forecast by region, 2017-2025
5.2.7. Fibroblasts
5.2.7.1. Historical market size by region, 2014-2016
5.2.7.2. Market forecast by region, 2017-2025
5.2.8. Neural stem cells
5.2.8.1. Historical market size by region, 2014-2016
5.2.8.2. Market forecast by region, 2017-2025
5.2.9. Gene-activated matrices
5.2.9.1. Historical market size by region, 2014-2016
5.2.9.2. Market forecast by region, 2017-2025
5.3. Pharmaceuticals
5.3.1. Historical market size by region, 2014-2016
5.3.2. Market forecast by region, 2017-2025
5.3.3. Small molecules
5.3.3.1. Historical market size by region, 2014-2016
5.3.3.2. Market forecast by region, 2017-2025
5.3.4. Biologics
5.3.4.1. Historical market size by region, 2014-2016
5.3.4.2. Market forecast by region, 2017-2025
5.4. Biologically derived materials
5.4.1. Historical market size by region, 2014-2016
5.4.2. Market forecast by region, 2017-2025
5.4.3. Collagen
5.4.3.1. Historical market size by region, 2014-2016
5.4.3.2. Market forecast by region, 2017-2025
5.4.4. Xenogeneic material
5.4.4.1. Historical market size by region, 2014-2016
5.4.4.2. Market forecast by region, 2017-2025
6. GLOBAL REGENERATIVE MEDICINES MARKET BY APPLICATION
6.1. Cardiovascular
6.1.1. Historical market size by region, 2014-2016
6.1.2. Market forecast by region, 2017-2025
6.2. Ophthalmology
6.2.1. Historical market size by region, 2014-2016
6.2.2. Market forecast by region, 2017-2025
6.3. Dermatology
6.3.1. Historical market size by region, 2014-2016
6.3.2. Market forecast by region, 2017-2025
6.4. Musculoskeletal
6.4.1. Historical market size by region, 2014-2016
6.4.2. Market forecast by region, 2017-2025
6.5. Wound healing
6.5.1. Historical market size by region, 2014-2016
6.5.2. Market forecast by region, 2017-2025
6.6. Oncology
6.6.1. Historical market size by region, 2014-2016
6.6.2. Market forecast by region, 2017-2025
6.7. Neurology
6.7.1. Historical market size by region, 2014-2016
6.7.2. Market forecast by region, 2017-2025
6.8. Others
6.8.1. Historical market size by region, 2014-2016
6.8.2. Market forecast by region, 2017-2025
7. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY
7.1. North America
7.1.1. U.S.
7.1.1.1. Historical market size, 2014-2016
7.1.1.2. Market forecast, 2017-2025
7.1.2. Canada
7.1.2.1. Historical market size, 2014-2016
7.1.2.2. Market forecast, 2017-2025
7.1.3. Mexico
7.1.3.1. Historical market size, 2014-2016
7.1.3.2. Market forecast, 2017-2025
7.2. Europe
7.2.1. UK
7.2.1.1. Historical market size, 2014-2016
7.2.1.2. Market forecast, 2017-2025
7.2.2. Germany
7.2.2.1. Historical market size, 2014-2016
7.2.2.2. Market forecast, 2017-2025
7.2.3. France
7.2.3.1. Historical market size, 2014-2016
7.2.3.2. Market forecast, 2017-2025
7.2.4. Spain
7.2.4.1. Historical market size, 2014-2016
7.2.4.2. Market forecast, 2017-2025
7.2.5. Italy
7.2.5.1. Historical market size, 2014-2016
7.2.5.2. Market forecast, 2017-2025
7.2.6. Rest of Europe
7.2.6.1. Historical market size, 2014-2016
7.2.6.2. Market forecast, 2017-2025
7.3. Asia-Pacific
7.3.1. China
7.3.1.1. Historical market size, 2014-2016
7.3.1.2. Market forecast, 2017-2025
7.3.2. Japan
7.3.2.1. Historical market size, 2014-2016
7.3.2.2. Market forecast, 2017-2025
7.3.3. India
7.3.3.1. Historical market size, 2014-2016
7.3.3.2. Market forecast, 2017-2025
7.3.4. Australia
7.3.4.1. Historical market size, 2014-2016
7.3.4.2. Market forecast, 2017-2025
7.3.5. South Korea
7.3.5.1. Historical market size, 2014-2016
7.3.5.2. Market forecast, 2017-2025
7.3.6. Rest of Asia-Pacific
7.3.6.1. Historical market size, 2014-2016
7.3.6.2. Market forecast, 2017-2025
7.4. LAMEA
7.4.1. Brazil
7.4.1.1. Historical market size, 2014-2016
7.4.1.2. Market forecast, 2017-2025
7.4.2. Saudi Arabia
7.4.2.1. Historical market size, 2014-2016
7.4.2.2. Market forecast, 2017-2025
7.4.3. South Africa
7.4.3.1. Historical market size, 2014-2016
7.4.3.2. Market forecast, 2017-2025
7.4.4. Rest of LAMEA
7.4.4.1. Historical market size, 2014-2016
7.4.4.2. Market forecast, 2017-2025
8. COMPANY PROFILES
8.1. Zimmer biomet holdings, inc.
8.1.1. Overview
8.1.2. Financials and business segments
8.1.3. Recent developments
8.2. Medtronic plc
8.2.1. Overview
8.2.2. Financials and business segments
8.2.3. Recent developments
8.3. Stryker corporation
8.3.1. Overview
8.3.2. Financials and business segments
8.3.3. Recent developments
8.4. Ocata therapeutics, inc.
8.4.1. Overview
8.4.2. Financials and business segments
8.4.3. Recent developments
8.5. Baxter international, inc.
8.5.1. overview
8.5.2. Financials and business segments
8.5.3. Recent developments
8.6. Depuy synthes
8.6.1. Overview
8.6.2. Financials and business segments
8.6.3. Recent developments
8.7. Organogenesis, inc.
8.7.1. Overview
8.7.2. Financials and business segments
8.7.3. Recent developments
8.8. Integra lifesciences holdings corporation
8.8.1. Overview
8.8.2. Financials and business segments
8.8.3. Recent developments
8.9. Acelity holdings, inc.
8.9.1. overview
8.9.2. Financials and business segments
8.9.3. Recent developments
8.10. Cryolife, inc.
8.10.1. Overview
8.10.2. Financials and business segments
8.10.3. Recent developments
LIST OF TABLES
Table 1. Regenerative Medicines Market Share, by Type, 2014-2025
Table 2. Regenerative Medicines Market Share, by Material, 2014-2025
Table 3. Regenerative Medicines Market Share, by Application, 2014-2025
Table 4. Regenerative Medicines Market Share, by Region, 2014-2025
Table 5. Regenerative Medicines Market Value for Tissue Engineering , by Region, 2017-2025, $million
Table 6. Regenerative Medicines Market Value for Cell Therapy, by Region, 2017-2025, $million
Table 7. Regenerative Medicines Market Value for Small Molecules & Biologics, by Region, 2017-2025, $million
Table 8. Regenerative Medicines Market Value for Gene Therapy, by Region, 2017-2025, $million
Table 9. Regenerative Medicines Market Value for Synthetic Materials, by Type, 2014-2025, $million
Table 10. Regenerative Medicines Market Value for Synthetic Materials, by Region, 2017-2025, $million
Table 11. Regenerative Medicines Market Value for Biodegradable Synthetic Polymers, by Region, 2017-2025, $million
Table 12. Regenerative Medicines Market Value for Hydrogel Material, by Region, 2017-2025, $million
Table 13. Regenerative Medicines Market Value for Scaffold, by Region, 2017-2025, $million
Table 14. Regenerative Medicines Market Value for Artificial Vascular Graft Materials, by Region, 2017-2025, $million
Table 15. Regenerative Medicines Market Value for Genetically Engineered Materials, by Type, 2014-2025, $million
Table 16. Regenerative Medicines Market Value for Genetically Engineered Materials, by Region, 2017-2025, $million
Table 17. Regenerative Medicines Market Value for Deoxyribonucleic Acid Transfection Vectors, by Region, 2017-2025, $million
Table 18. Regenerative Medicines Market Value for Genetically Manipulated Cells, by Region, 2017-2025, $million
Table 19. Regenerative Medicines Market Value for Three-Dimensional Polymer Technology, by Region, 2017-2025, $million
Table 20. Regenerative Medicines Market Value for Transgenic, by Region, 2017-2025, $million
Table 21. Regenerative Medicines Market Value for Fibroblasts, by Region, 2017-2025, $million
Table 22. Regenerative Medicines Market Value for Neural Stem Cells, by Region, 2017-2025, $million
Table 23. Regenerative Medicines Market Value for Gene-Activated Matrices, by Region, 2017-2025, $million
Table 24. Regenerative Medicines Market Value for Pharmaceuticals, by Type, 2014-2025, $million
Table 25. Regenerative Medicines Market Value for Pharmaceuticals, by Region, 2017-2025, $million
Table 26. Regenerative Medicines Market Value for Small Molecules, by Region, 2017-2025, $million
Table 27. Regenerative Medicines Market Value for Biologics, by Region, 2017-2025, $million
Table 28. Regenerative Medicines Market Value for Biologically Derived Materials, by Type, 2017-2025, $million
Table 29. Regenerative Medicines Market Value for Biologically Derived Materials, by Region, 2017-2025, $million
Table 30. Regenerative Medicines Market Value for Collagen, by Region, 2017-2025, $million
Table 31. Regenerative Medicines Market Value for Xenogeneic Material, by Region, 2017-2025, $million
Table 32. Regenerative Medicines Market Value for Cardiovascular, by Region, 2017-2025, $million
Table 33. Regenerative Medicines Market Value for Ophthalmology, by Region, 2017-2025, $million
Table 34. Regenerative Medicines Market Value for Dermatology, by Region, 2017-2025, $million
Table 35. Regenerative Medicines Market Value for Musculoskeletal, by Region, 2017-2025, $million
Table 36. Regenerative Medicines Market Value for Wound Healing, by Region, 2017-2025, $million
Table 37. Regenerative Medicines Market Value for Oncology, by Region, 2017-2025, $million
Table 38. Regenerative Medicines Market Value for Neurology, by Region, 2017-2025, $million
Table 39. Regenerative Medicines Market Value for Others Application, by Region, 2017-2025, $million
Table 40. Regenerative Medicines Market Value for North America, by Country, 2017-2025, $million
Table 41. Regenerative Medicines Market Value for North America, by Type, 2014-2025, $million
Table 42. Regenerative Medicines Market Value for North America, by Material, 2014-2025, $million
Table 43. Regenerative Medicines Market Value for North America, by Application, 2014-2025, $million
Table 44. Regenerative Medicines Market Value for Europe, by Country, 2014-2025, $million
Table 45. Regenerative Medicines Market Value for Europe, by Type, 2014-2025, $million
Table 46. Regenerative Medicines Market Value for Europe, by Material, 2014-2025, $million
Table 47. Regenerative Medicines Market Value for Europe, by Application, 2014-2025, $million
Table 48. Regenerative Medicines Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 49. Regenerative Medicines Market Value for Asia-Pacific, by Type, 2014-2025, $million
Table 50. Regenerative Medicines Market Value for Asia-Pacific, by Material, 2014-2025, $million
Table 51. Regenerative Medicines Market Value for Asia-Pacific, by Application, 2014-2025, $million
Table 52. Regenerative Medicines Market Value for LAMEA, by Country, 2014-2025, $million
Table 53. Regenerative Medicines Market Value for LAMEA, by Type, 2014-2025, $million
Table 54. Regenerative Medicines Market Value for LAMEA, by Material, 2014-2025, $million
Table 55. Regenerative Medicines Market Value for LAMEA, by Application, 2014-2025, $million
Table 56. Zimmer Biomet Holdings, Inc. - Company Snapshot
Table 57. Medtronic plc - Company Snapshot
Table 58. Stryker Corporation - Company Snapshot
Table 59. Ocata Therapeutics, Inc. - Company Snapshot
Table 60. Baxter International, Inc. - Company Snapshot
Table 61. DePuy Synthes - Company Snapshot
Table 62. Organogenesis, Inc. , - Company Snapshot
Table 63. Integra Lifesciences Holdings Corporation - Company Snapshot
Table 64. Acelity Holdings, Inc. - Company Snapshot
Table 65. CryoLife, Inc. - Company Snapshot
Table 1. Regenerative Medicines Market Share, by Type, 2014-2025
Table 2. Regenerative Medicines Market Share, by Material, 2014-2025
Table 3. Regenerative Medicines Market Share, by Application, 2014-2025
Table 4. Regenerative Medicines Market Share, by Region, 2014-2025
Table 5. Regenerative Medicines Market Value for Tissue Engineering , by Region, 2017-2025, $million
Table 6. Regenerative Medicines Market Value for Cell Therapy, by Region, 2017-2025, $million
Table 7. Regenerative Medicines Market Value for Small Molecules & Biologics, by Region, 2017-2025, $million
Table 8. Regenerative Medicines Market Value for Gene Therapy, by Region, 2017-2025, $million
Table 9. Regenerative Medicines Market Value for Synthetic Materials, by Type, 2014-2025, $million
Table 10. Regenerative Medicines Market Value for Synthetic Materials, by Region, 2017-2025, $million
Table 11. Regenerative Medicines Market Value for Biodegradable Synthetic Polymers, by Region, 2017-2025, $million
Table 12. Regenerative Medicines Market Value for Hydrogel Material, by Region, 2017-2025, $million
Table 13. Regenerative Medicines Market Value for Scaffold, by Region, 2017-2025, $million
Table 14. Regenerative Medicines Market Value for Artificial Vascular Graft Materials, by Region, 2017-2025, $million
Table 15. Regenerative Medicines Market Value for Genetically Engineered Materials, by Type, 2014-2025, $million
Table 16. Regenerative Medicines Market Value for Genetically Engineered Materials, by Region, 2017-2025, $million
Table 17. Regenerative Medicines Market Value for Deoxyribonucleic Acid Transfection Vectors, by Region, 2017-2025, $million
Table 18. Regenerative Medicines Market Value for Genetically Manipulated Cells, by Region, 2017-2025, $million
Table 19. Regenerative Medicines Market Value for Three-Dimensional Polymer Technology, by Region, 2017-2025, $million
Table 20. Regenerative Medicines Market Value for Transgenic, by Region, 2017-2025, $million
Table 21. Regenerative Medicines Market Value for Fibroblasts, by Region, 2017-2025, $million
Table 22. Regenerative Medicines Market Value for Neural Stem Cells, by Region, 2017-2025, $million
Table 23. Regenerative Medicines Market Value for Gene-Activated Matrices, by Region, 2017-2025, $million
Table 24. Regenerative Medicines Market Value for Pharmaceuticals, by Type, 2014-2025, $million
Table 25. Regenerative Medicines Market Value for Pharmaceuticals, by Region, 2017-2025, $million
Table 26. Regenerative Medicines Market Value for Small Molecules, by Region, 2017-2025, $million
Table 27. Regenerative Medicines Market Value for Biologics, by Region, 2017-2025, $million
Table 28. Regenerative Medicines Market Value for Biologically Derived Materials, by Type, 2017-2025, $million
Table 29. Regenerative Medicines Market Value for Biologically Derived Materials, by Region, 2017-2025, $million
Table 30. Regenerative Medicines Market Value for Collagen, by Region, 2017-2025, $million
Table 31. Regenerative Medicines Market Value for Xenogeneic Material, by Region, 2017-2025, $million
Table 32. Regenerative Medicines Market Value for Cardiovascular, by Region, 2017-2025, $million
Table 33. Regenerative Medicines Market Value for Ophthalmology, by Region, 2017-2025, $million
Table 34. Regenerative Medicines Market Value for Dermatology, by Region, 2017-2025, $million
Table 35. Regenerative Medicines Market Value for Musculoskeletal, by Region, 2017-2025, $million
Table 36. Regenerative Medicines Market Value for Wound Healing, by Region, 2017-2025, $million
Table 37. Regenerative Medicines Market Value for Oncology, by Region, 2017-2025, $million
Table 38. Regenerative Medicines Market Value for Neurology, by Region, 2017-2025, $million
Table 39. Regenerative Medicines Market Value for Others Application, by Region, 2017-2025, $million
Table 40. Regenerative Medicines Market Value for North America, by Country, 2017-2025, $million
Table 41. Regenerative Medicines Market Value for North America, by Type, 2014-2025, $million
Table 42. Regenerative Medicines Market Value for North America, by Material, 2014-2025, $million
Table 43. Regenerative Medicines Market Value for North America, by Application, 2014-2025, $million
Table 44. Regenerative Medicines Market Value for Europe, by Country, 2014-2025, $million
Table 45. Regenerative Medicines Market Value for Europe, by Type, 2014-2025, $million
Table 46. Regenerative Medicines Market Value for Europe, by Material, 2014-2025, $million
Table 47. Regenerative Medicines Market Value for Europe, by Application, 2014-2025, $million
Table 48. Regenerative Medicines Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 49. Regenerative Medicines Market Value for Asia-Pacific, by Type, 2014-2025, $million
Table 50. Regenerative Medicines Market Value for Asia-Pacific, by Material, 2014-2025, $million
Table 51. Regenerative Medicines Market Value for Asia-Pacific, by Application, 2014-2025, $million
Table 52. Regenerative Medicines Market Value for LAMEA, by Country, 2014-2025, $million
Table 53. Regenerative Medicines Market Value for LAMEA, by Type, 2014-2025, $million
Table 54. Regenerative Medicines Market Value for LAMEA, by Material, 2014-2025, $million
Table 55. Regenerative Medicines Market Value for LAMEA, by Application, 2014-2025, $million
Table 56. Zimmer Biomet Holdings, Inc. - Company Snapshot
Table 57. Medtronic plc - Company Snapshot
Table 58. Stryker Corporation - Company Snapshot
Table 59. Ocata Therapeutics, Inc. - Company Snapshot
Table 60. Baxter International, Inc. - Company Snapshot
Table 61. DePuy Synthes - Company Snapshot
Table 62. Organogenesis, Inc. , - Company Snapshot
Table 63. Integra Lifesciences Holdings Corporation - Company Snapshot
Table 64. Acelity Holdings, Inc. - Company Snapshot
Table 65. CryoLife, Inc. - Company Snapshot
LIST OF FIGURES
Figure 1. Regenerative Medicines Tissue Engineering Market Value, 2014-2016, $million
Figure 2. Regenerative Medicines Cell Therapy Market Value, 2014-2016, $million
Figure 3. Regenerative Medicines Small Molecules & Biologics Market Value, 2014-2016, $million
Figure 4. Regenerative Medicines Gene Therapy Market Value, 2014-2016, $million
Figure 5. Regenerative Medicines Synthetic Materials Market Value, 2014-2016, $million
Figure 6. Regenerative Medicines Biodegradable Synthetic Polymers Market Value, 2014-2016, $million
Figure 7. Regenerative Medicines Hydrogel Material Market Value, 2014-2016, $million
Figure 8. Regenerative Medicines Scaffold Market Value, 2014-2016, $million
Figure 9. Regenerative Medicines Artificial Vascular Graft Materials Market Value, 2014-2016, $million
Figure 10. Regenerative Medicines Genetically Engineered Materials Market Value, 2014-2016, $million
Figure 11. Regenerative Medicines Deoxyribonucleic Acid Transfection Vectors Market Value, 2014-2016, $million
Figure 12. Regenerative Medicines Genetically Manipulated Cells Market Value, 2014-2016, $million
Figure 13. Regenerative Medicines Three-Dimensional Polymer Technology Market Value, 2014-2016, $million
Figure 14. Regenerative Medicines Transgenic Market Value, 2014-2016, $million
Figure 15. Regenerative Medicines Fibroblasts Market Value, 2014-2016, $million
Figure 16. Regenerative Medicines Neural Stem Cells Market Value, 2014-2016, $million
Figure 17. Regenerative Medicines Gene-Activated Matrices Market Value, 2014-2016, $million
Figure 18. Regenerative Medicines Pharmaceuticals Market Value, 2014-2016, $million
Figure 19. Regenerative Medicines Small Molecules Market Value, 2014-2016, $million
Figure 20. Regenerative Medicines Biologics Market Value, 2014-2016, $million
Figure 21. Regenerative Medicines Biologically Derived Materials Market Value, 2014-2016, $million
Figure 22. Regenerative Medicines Collagen Market Value, 2014-2016, $million
Figure 23. Regenerative Medicines Xenogeneic Material Market Value, 2014-2016, $million
Figure 24. Regenerative Medicines Cardiovascular Market Value, 2014-2016, $million
Figure 25. Regenerative Medicines Ophthalmology Market Value, 2014-2016, $million
Figure 26. Regenerative Medicines Dermatology Market Value, 2014-2016, $million
Figure 27. Regenerative Medicines Musculoskeletal Market Value, 2014-2016, $million
Figure 28. Regenerative Medicines Wound Healing Market Value, 2014-2016, $million
Figure 29. Regenerative Medicines Oncology Market Value, 2014-2016, $million
Figure 30. Regenerative Medicines Neurology Market Value, 2014-2016, $million
Figure 31. Regenerative Medicines Other Applications Market Value, 2014-2016, $million
Figure 32. Regenerative Medicines: U.S. Market Value, 2014-2016, $million
Figure 33. Regenerative Medicines: U.S. Market Value, 2017-2025, $million
Figure 34. Regenerative Medicines: Canada Market Value, 2014-2016, $million
Figure 35. Regenerative Medicines: Canada Market Value, 2017-2025, $million
Figure 36. Regenerative Medicines: Mexico Market Value, 2014-2016, $million
Figure 37. Regenerative Medicines: Mexico Market Value, 2017-2025, $million
Figure 38. Regenerative Medicines: UK Market Value, 2014-2016, $million
Figure 39. Regenerative Medicines: UKMarket Value, 2017-2025, $million
Figure 40. Regenerative Medicines: Germany Market Value, 2014-2016, $million
Figure 41. Regenerative Medicines: Germany Market Value, 2017-2025, $million
Figure 42. Regenerative Medicines: France Market Value, 2014-2016, $million
Figure 43. Regenerative Medicines: France Market Value, 2017-2025, $million
Figure 44. Regenerative Medicines: Spain Market Value, 2014-2016, $million
Figure 45. Regenerative Medicines: Spain Market Value, 2017-2025, $million
Figure 46. Regenerative Medicines: Italy Market Value, 2014-2016, $million
Figure 47. Regenerative Medicines: Italy Market Value, 2017-2025, $million
Figure 48. Regenerative Medicines: Rest of Europe Market Value, 2014-2016, $million
Figure 49. Regenerative Medicines: Rest of Europe Market Value, 2017-2025, $million
Figure 50. Regenerative Medicines: China Market Value, 2014-2016, $million
Figure 51. Regenerative Medicines: China Market Value, 2017-2025, $million
Figure 52. Regenerative Medicines: Japan Market Value, 2014-2016, $million
Figure 53. Regenerative Medicines: Japan Market Value, 2017-2025, $million
Figure 54. Regenerative Medicines: India Market Value, 2014-2016, $million
Figure 55. Regenerative Medicines: India Market Value, 2017-2025, $million
Figure 56. Regenerative Medicines: Australia Market Value, 2014-2016, $million
Figure 57. Regenerative Medicines: Australia Market Value, 2017-2025, $million
Figure 58. Regenerative Medicines: South Korea Market Value, 2014-2016, $million
Figure 59. Regenerative Medicines: South Korea Market Value, 2017-2025, $million
Figure 60. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 61. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 62. Regenerative Medicines: Brazil Market Value, 2014-2016, $million
Figure 63. Regenerative Medicines: Brazil Market Value, 2017-2025, $million
Figure 64. Regenerative Medicines: Saudi Arabia Market Value, 2014-2016, $million
Figure 65. Regenerative Medicines: Saudi Arabia Market Value, 2017-2025, $million
Figure 66. Regenerative Medicines: South Africa Market Value, 2014-2016, $million
Figure 67. Regenerative Medicines: South Africa Market Value, 2017-2025, $million
Figure 68. Regenerative Medicines: Rest of LAMEA Market Value, 2014-2016, $million
Figure 69. Regenerative Medicines: Rest of LAME Market Value, 2017-2025, $million
COMPANIES MENTIONED
The top players in the global regenerative medicines market include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.
Figure 1. Regenerative Medicines Tissue Engineering Market Value, 2014-2016, $million
Figure 2. Regenerative Medicines Cell Therapy Market Value, 2014-2016, $million
Figure 3. Regenerative Medicines Small Molecules & Biologics Market Value, 2014-2016, $million
Figure 4. Regenerative Medicines Gene Therapy Market Value, 2014-2016, $million
Figure 5. Regenerative Medicines Synthetic Materials Market Value, 2014-2016, $million
Figure 6. Regenerative Medicines Biodegradable Synthetic Polymers Market Value, 2014-2016, $million
Figure 7. Regenerative Medicines Hydrogel Material Market Value, 2014-2016, $million
Figure 8. Regenerative Medicines Scaffold Market Value, 2014-2016, $million
Figure 9. Regenerative Medicines Artificial Vascular Graft Materials Market Value, 2014-2016, $million
Figure 10. Regenerative Medicines Genetically Engineered Materials Market Value, 2014-2016, $million
Figure 11. Regenerative Medicines Deoxyribonucleic Acid Transfection Vectors Market Value, 2014-2016, $million
Figure 12. Regenerative Medicines Genetically Manipulated Cells Market Value, 2014-2016, $million
Figure 13. Regenerative Medicines Three-Dimensional Polymer Technology Market Value, 2014-2016, $million
Figure 14. Regenerative Medicines Transgenic Market Value, 2014-2016, $million
Figure 15. Regenerative Medicines Fibroblasts Market Value, 2014-2016, $million
Figure 16. Regenerative Medicines Neural Stem Cells Market Value, 2014-2016, $million
Figure 17. Regenerative Medicines Gene-Activated Matrices Market Value, 2014-2016, $million
Figure 18. Regenerative Medicines Pharmaceuticals Market Value, 2014-2016, $million
Figure 19. Regenerative Medicines Small Molecules Market Value, 2014-2016, $million
Figure 20. Regenerative Medicines Biologics Market Value, 2014-2016, $million
Figure 21. Regenerative Medicines Biologically Derived Materials Market Value, 2014-2016, $million
Figure 22. Regenerative Medicines Collagen Market Value, 2014-2016, $million
Figure 23. Regenerative Medicines Xenogeneic Material Market Value, 2014-2016, $million
Figure 24. Regenerative Medicines Cardiovascular Market Value, 2014-2016, $million
Figure 25. Regenerative Medicines Ophthalmology Market Value, 2014-2016, $million
Figure 26. Regenerative Medicines Dermatology Market Value, 2014-2016, $million
Figure 27. Regenerative Medicines Musculoskeletal Market Value, 2014-2016, $million
Figure 28. Regenerative Medicines Wound Healing Market Value, 2014-2016, $million
Figure 29. Regenerative Medicines Oncology Market Value, 2014-2016, $million
Figure 30. Regenerative Medicines Neurology Market Value, 2014-2016, $million
Figure 31. Regenerative Medicines Other Applications Market Value, 2014-2016, $million
Figure 32. Regenerative Medicines: U.S. Market Value, 2014-2016, $million
Figure 33. Regenerative Medicines: U.S. Market Value, 2017-2025, $million
Figure 34. Regenerative Medicines: Canada Market Value, 2014-2016, $million
Figure 35. Regenerative Medicines: Canada Market Value, 2017-2025, $million
Figure 36. Regenerative Medicines: Mexico Market Value, 2014-2016, $million
Figure 37. Regenerative Medicines: Mexico Market Value, 2017-2025, $million
Figure 38. Regenerative Medicines: UK Market Value, 2014-2016, $million
Figure 39. Regenerative Medicines: UKMarket Value, 2017-2025, $million
Figure 40. Regenerative Medicines: Germany Market Value, 2014-2016, $million
Figure 41. Regenerative Medicines: Germany Market Value, 2017-2025, $million
Figure 42. Regenerative Medicines: France Market Value, 2014-2016, $million
Figure 43. Regenerative Medicines: France Market Value, 2017-2025, $million
Figure 44. Regenerative Medicines: Spain Market Value, 2014-2016, $million
Figure 45. Regenerative Medicines: Spain Market Value, 2017-2025, $million
Figure 46. Regenerative Medicines: Italy Market Value, 2014-2016, $million
Figure 47. Regenerative Medicines: Italy Market Value, 2017-2025, $million
Figure 48. Regenerative Medicines: Rest of Europe Market Value, 2014-2016, $million
Figure 49. Regenerative Medicines: Rest of Europe Market Value, 2017-2025, $million
Figure 50. Regenerative Medicines: China Market Value, 2014-2016, $million
Figure 51. Regenerative Medicines: China Market Value, 2017-2025, $million
Figure 52. Regenerative Medicines: Japan Market Value, 2014-2016, $million
Figure 53. Regenerative Medicines: Japan Market Value, 2017-2025, $million
Figure 54. Regenerative Medicines: India Market Value, 2014-2016, $million
Figure 55. Regenerative Medicines: India Market Value, 2017-2025, $million
Figure 56. Regenerative Medicines: Australia Market Value, 2014-2016, $million
Figure 57. Regenerative Medicines: Australia Market Value, 2017-2025, $million
Figure 58. Regenerative Medicines: South Korea Market Value, 2014-2016, $million
Figure 59. Regenerative Medicines: South Korea Market Value, 2017-2025, $million
Figure 60. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 61. Regenerative Medicines: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 62. Regenerative Medicines: Brazil Market Value, 2014-2016, $million
Figure 63. Regenerative Medicines: Brazil Market Value, 2017-2025, $million
Figure 64. Regenerative Medicines: Saudi Arabia Market Value, 2014-2016, $million
Figure 65. Regenerative Medicines: Saudi Arabia Market Value, 2017-2025, $million
Figure 66. Regenerative Medicines: South Africa Market Value, 2014-2016, $million
Figure 67. Regenerative Medicines: South Africa Market Value, 2017-2025, $million
Figure 68. Regenerative Medicines: Rest of LAMEA Market Value, 2014-2016, $million
Figure 69. Regenerative Medicines: Rest of LAME Market Value, 2017-2025, $million
COMPANIES MENTIONED
The top players in the global regenerative medicines market include Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc.
